Novartis paid Takeda $3.4 billion for its FDA-approved dry eye drug Xiidra during the Japanese pharma’s merger with Shire in 2019, outlining the sales potential in this market niche. But with ...

Premier Tim Houston and the 12 other provincial and territorial premiers will travel to Washington, D.C., next week to make their case about the significant benefits both the United States and Canada ...